(Q42620817)

English

The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study

scientific article published on April 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hormone Replacement Therapy

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

Per Morten Sandset

6

object named as

Sandset PM

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

author name string

Hoibraaten E

1

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Os I

2

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Seljeflot I

3

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Andersen TO

4

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Hofstad A

5

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Thrombosis Research

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

19-27

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An enzyme linked immunosorption assay for tissue factor pathway inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel principle for assessment of stimulated fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombosis and hormone replacement therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Coagulation activation following estrogen administration to postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of transdermal oestradiol and oral progestogens on haemostasis variables

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormone replacement therapy, inflammation, and hemostasis in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Coagulation effects of oral contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Haemostatic changes during continuous oestradiol-progestogen treatment of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemostatic factors according to menopausal status and use of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900233-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0049-3848(99)00233-9

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42620817&oldid=1963282172"